CONMED Corporation Announces Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Leerink Partners Downgrades CONMED (CNMD) to Market Perform
July 28, 2016 7:17 AM EDTLeerink Partners downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $47.00 (from $56.00).
Analyst Richard Newitter commented, "While we are encouraged by Airseal (Surgiquest) outperformance in the qtr, CNMD's organic revenue growth again missed expectations--on weak US ortho capital... More



